Ewing's sarcoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ewing's sarcoma}} | {{Ewing's sarcoma}} | ||
{{CMG}}; '''Assistant Editor(s)-In-Chief:''' [[User:Michael Maddaleni|Michael Maddaleni, B.S.]] | {{CMG}};{{AE}} {{PSK}};'''Assistant Editor(s)-In-Chief:''' [[User:Michael Maddaleni|Michael Maddaleni, B.S.]] | ||
==Overview== | ==Overview== | ||
Ewing sarcoma is the second most common malignant bone tumor in patients younger than 20 years. Ewing sarcoma typically occurs in children and adolescents between 10 and 20 years of age. The overall incidence of Ewing sarcoma is 0.1 cases for 100,000 individuals. The incidence of Ewing sarcoma in children aged 10 to 19 years is 1 case | Ewing's sarcoma is the second most common malignant bone tumor in patients younger than 20 years. Ewing's sarcoma typically occurs in children and adolescents between 10 and 20 years of age. The overall incidence of Ewing's sarcoma is 0.1 cases for 100,000 individuals. The incidence of Ewing's sarcoma in children aged 10 to 19 years is 1 case per 100,000 individuals. Males are more commonly affected with Ewing's sarcoma than females. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Ewing sarcoma is the second most common malignant bone tumor in patients younger than 20. The most frequent is [[osteosarcoma]].<ref name="pmid17272319">{{cite journal |author=Iwamoto Y |title=Diagnosis and treatment of Ewing's sarcoma |journal=[[Japanese Journal of Clinical Oncology]] |volume=37 |issue=2 |pages=79–89 |year=2007 |month=February |pmid=17272319 |doi=10.1093/jjco/hyl142 |url=http://jjco.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17272319 |accessdate=2011-12-21}}</ref> | Ewing's sarcoma is the second most common malignant bone tumor in patients younger than 20 years. The most frequent is [[osteosarcoma]].<ref name="pmid17272319">{{cite journal |author=Iwamoto Y |title=Diagnosis and treatment of Ewing's sarcoma |journal=[[Japanese Journal of Clinical Oncology]] |volume=37 |issue=2 |pages=79–89 |year=2007 |month=February |pmid=17272319 |doi=10.1093/jjco/hyl142 |url=http://jjco.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17272319 |accessdate=2011-12-21}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of Ewing sarcoma has remained unchanged for 30 years. | *The incidence of Ewing's sarcoma has remained unchanged for 30 years.<ref name=NIH>Ewing's sarcoma. National cancer institute.http://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#section/_1</ref> | ||
*The overall incidence of Ewing sarcoma is 0.1 cases | *The overall incidence of Ewing's sarcoma is 0.1 cases per 100,000 individuals. | ||
*The incidence of Ewing sarcoma in children aged 10 to 19 years is 1 case for 100,000 individuals. | *The incidence of Ewing's sarcoma in children aged 10 to 19 years is 1 case for 100,000 individuals. | ||
===Race=== | ===Race=== | ||
*Incidence of Ewing sarcoma in the United States is nine times greater in whites than in African Americans, with an intermediate incidence in Asians. | *Incidence of Ewing's sarcoma in the United States is nine times greater in whites than in African Americans, with an intermediate incidence in Asians.<ref name=NIH>Ewing's sarcoma. National cancer institute.http://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#section/_1</ref> | ||
*The relative paucity of Ewing sarcoma in people of African or Asian descent may be explained, in part, by a specific polymorphism. | *The relative paucity of Ewing's sarcoma in people of African or Asian descent may be explained, in part, by a specific polymorphism. | ||
*The polymorphism associated with the increased risk is found at a much higher frequency in whites than in blacks or Asians, possibly explaining the epidemiology of the relative infrequency of Ewing sarcoma in the latter populations. | *The polymorphism associated with the increased risk is found at a much higher frequency in whites than in blacks or Asians, possibly explaining the epidemiology of the relative infrequency of Ewing's sarcoma in the latter populations. | ||
* | *Ewing's sarcoma usually affects individuals of the Caucasian race. African American individuals are less likely to develop chordoma.<ref name="pmid17272319">{{cite journal |author=Iwamoto Y |title=Diagnosis and treatment of Ewing's sarcoma |journal=[[Japanese Journal of Clinical Oncology]] |volume=37 |issue=2 |pages=79–89 |year=2007 |month=February |pmid=17272319 |doi=10.1093/jjco/hyl142 |url=http://jjco.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17272319 |accessdate=2011-12-21}}</ref> | ||
===Age=== | ===Age=== | ||
*Ewing sarcoma typically occurs in children and adolescents between 10 and 20 years of age (95% between 4 and 25 years of age). | *Ewing's sarcoma typically occurs in children and adolescents between 10 and 20 years of age (95% between 4 and 25 years of age). | ||
*The median age at diagnosis of Ewing sarcoma is 15 years. | *The median age at diagnosis of Ewing's sarcoma is 15 years. | ||
*Well-characterized cases of Ewing sarcoma in neonates and infants have been described. | *Well-characterized cases of Ewing's sarcoma in neonates and infants have been described. | ||
*Review of the SEER database from 1973 to 2011 identified 1,957 patients with Ewing sarcoma. Thirty-nine of these patients (2.0%) were younger than 12 months at diagnosis. | *Review of the SEER database from 1973 to 2011 identified 1,957 patients with Ewing sarcoma. Thirty-nine of these patients (2.0%) were younger than 12 months at diagnosis. | ||
===Gender=== | ===Gender=== | ||
*Males are more commonly affected with Ewing sarcoma than females. | *Males are more commonly affected with Ewing's sarcoma than females. | ||
==References== | ==References== | ||
| Line 33: | Line 36: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Orthopedics]] | |||
Latest revision as of 23:19, 26 November 2017
|
Ewing's sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ewing's sarcoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ewing's sarcoma epidemiology and demographics |
|
Risk calculators and risk factors for Ewing's sarcoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2];Assistant Editor(s)-In-Chief: Michael Maddaleni, B.S.
Overview
Ewing's sarcoma is the second most common malignant bone tumor in patients younger than 20 years. Ewing's sarcoma typically occurs in children and adolescents between 10 and 20 years of age. The overall incidence of Ewing's sarcoma is 0.1 cases for 100,000 individuals. The incidence of Ewing's sarcoma in children aged 10 to 19 years is 1 case per 100,000 individuals. Males are more commonly affected with Ewing's sarcoma than females.
Epidemiology and Demographics
Ewing's sarcoma is the second most common malignant bone tumor in patients younger than 20 years. The most frequent is osteosarcoma.[1]
Incidence
- The incidence of Ewing's sarcoma has remained unchanged for 30 years.[2]
- The overall incidence of Ewing's sarcoma is 0.1 cases per 100,000 individuals.
- The incidence of Ewing's sarcoma in children aged 10 to 19 years is 1 case for 100,000 individuals.
Race
- Incidence of Ewing's sarcoma in the United States is nine times greater in whites than in African Americans, with an intermediate incidence in Asians.[2]
- The relative paucity of Ewing's sarcoma in people of African or Asian descent may be explained, in part, by a specific polymorphism.
- The polymorphism associated with the increased risk is found at a much higher frequency in whites than in blacks or Asians, possibly explaining the epidemiology of the relative infrequency of Ewing's sarcoma in the latter populations.
- Ewing's sarcoma usually affects individuals of the Caucasian race. African American individuals are less likely to develop chordoma.[1]
Age
- Ewing's sarcoma typically occurs in children and adolescents between 10 and 20 years of age (95% between 4 and 25 years of age).
- The median age at diagnosis of Ewing's sarcoma is 15 years.
- Well-characterized cases of Ewing's sarcoma in neonates and infants have been described.
- Review of the SEER database from 1973 to 2011 identified 1,957 patients with Ewing sarcoma. Thirty-nine of these patients (2.0%) were younger than 12 months at diagnosis.
Gender
- Males are more commonly affected with Ewing's sarcoma than females.
References
- ↑ 1.0 1.1 Iwamoto Y (2007). "Diagnosis and treatment of Ewing's sarcoma". Japanese Journal of Clinical Oncology. 37 (2): 79–89. doi:10.1093/jjco/hyl142. PMID 17272319. Retrieved 2011-12-21. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Ewing's sarcoma. National cancer institute.http://www.cancer.gov/types/bone/hp/ewing-treatment-pdq#section/_1